Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG) (S35.004)

J Howard; R Barohn; M Freimer; V Juel; T Mozaffar; M Mellion; M Benatar; M Farrugia; J Kissel; The MG Study Group

doi:10.1212/WNL.78.1_MeetingAbstracts.S35.004

$Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG) (S35.004)$

Journal article

Peer reviewed

Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG) (S35.004)

J Howard, R Barohn, M Freimer, V Juel, T Mozaffar, M Mellion, M Benatar, M Farrugia, J Kissel and The MG Study Group

Neurology, Vol.78(Meeting Abstracts 1), pp.S35-S35.004

2012-04-25

DOI: https://doi.org/10.1212/WNL.78.1_MeetingAbstracts.S35.004

Metrics

9 Record Views

Details

Title: Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG) (S35.004)
Creators: J Howard
R Barohn
M Freimer
V Juel
T Mozaffar
M Mellion
M Benatar
M Farrugia
J Kissel
The MG Study Group
Publication Details: Neurology, Vol.78(Meeting Abstracts 1), pp.S35-S35.004
Academic Unit: Miller School of Medicine; UMMG Department of Neurology; UMMG Dept of Neurology - Neuromuscular Disorders Div
Language: English
Resource Type: Journal article
Record Identifier: 991031598076802976